Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)

Overview of attention for article published in BMC Cancer, March 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,384 followers.

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for adva… https://t.co/bNhKDXYnA2

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for adva… http://t.co/bNhKDXYnA2

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.